Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Sarcoma 1CNS 1

Conditions

Glioma 3Wilms Tumor 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Chondrosarcoma 2Xanthogranuloma, Juvenile 1Lymphoma, Follicular 1Histiocytic Sarcoma 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1

Interventions

Nivolumab 3Quality of Life 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Fluorodeoxyglucose F18 2Drug Therapy 2Cisplatin 2trametinib 1tislelizumab 1spartalizumab 1seribantumab 1pembrolizumab 1pazopanib 1milademetan 1ivosidenib 1entrectinib 1enasidenib 1durvalumab 1crenigacestat 1apixaban 1alectinib 1abemaciclib 1Surveys and Questionnaires 1Specimen Handling 1Rivaroxaban 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Metformin 1LY3023414 1LY2940680 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × ivosidenib × Sarcoma × Clear all
NCT02073994 2026-02-17

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

Servier

Phase 1 Completed
174 enrolled
CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡